About
CEVR Team
Careers
Read for the Registry
Contact Us
News & Events
News
Events
Publications
Databases
CEA Registry
GH CEA Registry
SPEC Database
Sponsorship
Sponsor login
Contact Us
News & Events
News
CEVR Appoints New Experts to CEA Registry Scientific Advisory Board and Discusses Priorities for 2024
Date: October 30, 2023 CEVR is pleased to welcome two new Advisors to the CEA Registry’s Scientific Advisory Board: Elena Elkin, PhD, Professor of He...
An Inside View of the Tufts-CEVR CEA Registry Summer Fellowship
A Conversation with 2023 Fellowship Alumna, Divya Patil Divya Patil, MS, completed our Tufts-CEVR CEA Registry Fellowship during the summer of 2023. A...
CALL FOR PAPERS: 2023 TUFTS-CEVR COST-EFFECTIVENESS ANALYSIS PAPER OF THE YEAR AWARD
The Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts Medical Center is now accepting submissions for the 6th annual Cost-Effectiv...
View All News Items
Events
CEVR Webinar with James Chambers - "US Payer Coverage of Specialty Drugs: Outlook for 2024"
Health Policy Seminar with Zach Rivers, PharmD, PhD
Health Policy Seminar with Victoria Fan, ScD
View All Events
Publications
Health Policy Open
Variation in Medicaid and commercial coverage of cell and gene therapies
Health Affairs Forefront
The Case For Including Dynamic Drug Pricing In Cost-Effectiveness Analyses Under The IRA
The American Journal of Managed Care
Varied Use of Step Therapy Among Medicare Advantage Plans
The Milbank Quarterly
Improving Food and Drug Administration–Centers for Medicare and Medicaid Services Coordination for Drugs Granted Accelerated Approval
Cost Effectiveness and Resource Allocation
Assessing the impact of grief on quality of life, work productivity, and health outcomes for parents bereaved from SMA: A study protocol
The New England Journal of Medicine
Turning CMS into a health technology assessment organization
JAMA Network Open
Follow-On Indications for Orphan Drugs Related to the Inflation Reduction Act
Journal of Market Access & Health Policy
Rule of Prevention: a potential framework to evaluate preventive interventions for rare diseases
Health Affairs Scholar
Commercial Coverage of Specialty Drugs 2017-2021
View All Publications